Down syndrome and Alzheimer’s disease: A scoping review of functional performance and fall risk
As with the general aging adult population, there is an urgent need to understand the preclinical and early phases of AD (Alzheimer disease) progression in the adult population with DS. The aim of this scoping review was to synthesize the current state of the evidence and identify gaps in the literature regarding functional activity performance
Ketogenic diet acutely improves cognitive function in patient with Down syndrome and Alzheimer’s disease
47-year-old woman with Down syndrome presented with the complaints of fear, anxiety, confusion and memory loss.Because of her change in behavior, fear, and anxiety, she became largely housebound and struggled with fatigue, took extended naps once or twice daily, and could no longer safely be left alone for extended periods. Her primary